BioNexus Gene Lab Cash Flow Statement (2018-2026) | BGLC

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
0.03M0.30M0.12M0.02M-0.14M-0.08M0.07M-0.07M-0.29M-2.61M0.35M-0.06M0.20M-1.35M-0.33M-0.62M-0.62M-0.71M-1.04M-0.54M
Depreciation and Depletion (Quarter)
0.04M0.02M0.02M0.02M0.02M0.02M0.02M0.02M-0.02M0.06M0.02M0.02M0.02M0.03M0.03M0.03M0.03M0.03M0.03M0.03M
Share-based Compensation (Quarter)
-0.09M0.79M
Deferred Taxes (Quarter)
0.00M0.02M
Gains from Investment Securities (Quarter)
-0.01M0.02M-0.02M4.00-4.000.01M0.01M0.04M0.01M0.00M360.00
Asset Writedowns and Impairment (Quarter)
0.00M97.000.00M0.00M0.76M0.04M0.18M-0.22M0.20M
Non-cash Items (Quarter)
0.04M-0.06M0.00M-0.09M-0.05M-1.01M-0.79M-0.04M-0.34M-1.46M-0.51M
Cash from Operations (Quarter)
-0.91M0.32M0.48M-0.04M-0.20M0.31M0.48M-0.12M-0.02M-0.90M-0.78M-0.04M-0.67M-1.60M0.22M-0.82M-0.74M-1.24M0.96M-0.15M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.01M0.01M0.01M0.01M0.01M0.01M0.01M
Amortization of Deferred Charges (Quarter)
0.00M0.00M0.00M0.00M0.00M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.02M
Depreciation & Amortization (CF) (Quarter)
0.04M0.02M0.02M0.02M0.02M0.02M0.02M0.02M-0.02M0.06M0.02M0.02M0.02M0.03M0.03M0.03M0.03M0.03M0.03M0.03M
Change in Working Capital
Change in Receivables (Quarter)
-0.33M-0.20M-0.11M-0.34M-0.02M-0.15M1.16M-0.11M0.12M-0.15M0.00M0.11M0.26M-0.21M-0.94M-0.24M
Change in Inventory (Quarter)
-0.82M0.22M-0.03M0.13M-0.14M-0.42M0.97M-0.08M0.27M-0.06M-0.29M0.06M-0.17M0.36M-452.00-0.21M0.04M-0.21M-0.33M-0.01M
Change in Account Payables (Quarter)
-0.54M0.05M-0.39M-0.21M-0.43M-0.13M0.65M-0.43M0.32M-0.25M-0.02M0.06M-0.51M0.20M0.46M-0.32M0.20M-1.11M-0.16M0.19M
Change in Taxes (Quarter)
-3.00
Other Working Capital Changes (Quarter)
0.08M-0.08M
Investing Activities
Capital Expenditures (Quarter)
666.00410.000.00M0.03M0.00M-0.03M0.51M0.01M0.03M0.11M937.000.02M0.00M0.20M0.00M0.01M0.02M0.01M977.00325.00
Sales of Property, Plant and Equipment (Quarter)
Divestments (Quarter)
0.01M0.01M0.01M0.02M0.08M0.01M0.01M0.20M0.57M0.01M
Change in Acquisitions & Divestments (Quarter)
-52.00-22.000.03M-708.000.21M0.09M0.20M0.57M
Cash from Investing Activities (Quarter)
-0.06M-0.06M-0.08M-0.20M-0.22M0.02M-0.05M-0.01M-0.00M-0.36M-1.43M0.00M0.06M-0.20M0.55M-0.02M-0.03M0.99M-0.01M-0.01M
Financing Activities
Other financing activities (Quarter)
0.00M0.00M
Cash from Financing Activities (Quarter)
-0.01M-0.01M-0.00M0.11M-0.00M-0.00M-0.00M-0.00M5.75M0.53M0.03M0.18M-0.06M-0.14M-860.00-0.00M0.03M0.27M0.06M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
Dividend Payments
Dividends Paid - Common (Quarter)
0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Additional items
Exchange Rate Effect (Quarter)
-0.03M0.02M-0.04M-0.20M-0.20M0.23M-0.02M-0.19M-0.10M0.05M-0.07M-0.04M0.57M-0.41M0.04M0.22M0.03M-0.09M0.01M
Change in Cash (Quarter)
-0.99M0.22M0.42M-0.28M-0.50M1.45M-0.67M-0.15M-0.21M4.39M-1.63M-0.08M-0.48M-1.30M0.22M-0.80M-0.55M-0.18M1.13M-0.09M
Free Cash Flow (Quarter)
-0.91M0.32M0.48M-0.07M-0.20M0.34M-0.03M-0.13M-0.05M-1.01M-0.78M-0.06M-0.67M-1.80M0.22M-0.83M-0.76M-1.24M0.96M-0.15M
Net Cash Flow (Quarter)
-0.97M0.25M0.40M-0.23M-0.31M0.33M0.42M-0.12M-0.03M4.49M-1.68M-0.01M-0.43M-1.86M0.63M-0.84M-0.77M-0.21M1.22M-0.10M